| |
| |
|
| Insider
Information: |
Baker/tisch Investments, Lp |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
400,961 |
|
|
Indirect Shares
|
7,642,042 |
|
|
| Direct
Value |
$12,317,574 |
|
|
|
Indirect Value
|
$484,811,144 |
|
|
| Total
Shares |
8,043,003 |
|
|
| Total
Value |
$497,128,718 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
Director |
2012-07-13 |
206,800 |
|
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-07-26 |
194,161 |
2019-10-01 |
7,642,042 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHDX |
Genomic Health Inc |
Director |
– • • |
2019-10-01 |
4 |
A |
$67.28 |
$124,468 |
I/I |
1,850 |
7,642,042 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2019-01-01 |
4 |
A |
$64.41 |
$119,803 |
I/I |
1,860 |
295,934 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-12-07 |
4 |
S |
$76.15 |
$7,802,358 |
I/I |
(102,455) |
9,754,128 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-12-06 |
4 |
S |
$75.46 |
$6,993,622 |
I/I |
(92,679) |
9,838,546 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-12-03 |
4 |
S |
$76.62 |
$15,865,833 |
I/I |
(202,134) |
9,941,916 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-30 |
4 |
S |
$79.07 |
$16,217,022 |
I/I |
(204,757) |
10,108,467 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-29 |
4 |
S |
$77.61 |
$3,997,191 |
I/I |
(51,278) |
10,277,179 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-28 |
4 |
S |
$74.01 |
$18,932,283 |
I/I |
(250,392) |
10,319,430 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-12 |
4 |
S |
$80.38 |
$1,158,724 |
I/I |
(14,415) |
11,007,633 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-09 |
4 |
S |
$82.06 |
$13,972,201 |
I/I |
(169,344) |
11,019,510 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-09 |
4 |
S |
$82.00 |
$9,018,337 |
I/I |
(107,738) |
11,159,044 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-08 |
4 |
S |
$83.94 |
$6,225,158 |
I/I |
(72,745) |
11,310,659 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-08 |
4 |
S |
$83.85 |
$6,597,504 |
I/I |
(76,273) |
11,247,815 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-10-01 |
4 |
A |
$70.18 |
$119,587 |
I/I |
1,704 |
340,265 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-07-01 |
4 |
A |
$50.40 |
$119,750 |
I/I |
2,376 |
339,981 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-03-09 |
4 |
OE |
$18.50 |
$915,750 |
I/I |
49,500 |
338,947 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-01-01 |
4 |
A |
$34.20 |
$119,837 |
I/I |
3,504 |
330,697 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2017-10-01 |
4 |
A |
$32.09 |
$119,760 |
I/I |
3,732 |
330,113 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2017-05-31 |
4 |
OE |
$18.13 |
$897,435 |
I/I |
49,500 |
328,877 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2017-04-01 |
4 |
A |
$31.49 |
$119,788 |
I/I |
3,804 |
320,627 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2017-01-01 |
4 |
A |
$29.39 |
$119,911 |
I/I |
4,080 |
319,993 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
194,161 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
206,800 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
